The Immune Tolerance Network is dedicated to the clinical evaluation of novel tolerance-inducing therapies that will re-educate the immune system to eliminate injurious immune responses and graft rejection. The ITN conducts clinical trials that include novel tolerance-inducing therapies for liver transplantation, kidney transplantation, bone marrow transplantation, and the prevention of graft rejection. In addition, to understand the underlying mechanisms of action of the candidate therapies and to monitor tolerance, the ITN has established state of the art core laboratory facilities to conduct integrated mechanistic studies, and to develop and evaluate markers and assays to measure induction, maintenance, and loss of tolerance in humans.

Project Start
2001-09-30
Project End
2014-04-30
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
$13,422,595
Indirect Cost